This clinical trial is focused on preventing infections that can occur after surgery on the colon or rectum, known as colorectal surgery. The study is investigating the use of a medication called cefoxitin, which is an antibiotic that helps fight bacteria. The trial will compare two different ways of giving this medication: one group will receive it in regular doses, while the other group will receive an initial larger dose followed by a continuous infusion. The goal is to see which method is more effective in preventing infections at the site of surgery.
Participants in the study will be adults undergoing colorectal surgery. The study will last for a period of time after the surgery to monitor for any signs of infection. During this time, researchers will check for any infections that occur within 30 days after the surgery. The study will also look at other outcomes, such as the need for additional surgery, any complications, and the length of hospital stay.
The trial is designed to be a fair test, meaning neither the participants nor the researchers will know which treatment each participant is receiving. This is known as a “double-blind” study. The purpose of the study is to find out if the new method of giving cefoxitin is better at preventing infections compared to the standard method. This information could help improve care for patients undergoing colorectal surgery in the future.



France